These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 1590697)
1. Lipid complexing decreases amphotericin B inflammatory activation of human neutrophils compared with that of a desoxycholate-suspended preparation of amphotericin B (Fungizone). Sullivan GW; Carper HT; Mandell GL Antimicrob Agents Chemother; 1992 Jan; 36(1):39-45. PubMed ID: 1590697 [TBL] [Abstract][Full Text] [Related]
2. Pentoxifylline modulates activation of human neutrophils by amphotericin B in vitro. Sullivan GW; Carper HT; Mandell GL Antimicrob Agents Chemother; 1992 Feb; 36(2):408-16. PubMed ID: 1318681 [TBL] [Abstract][Full Text] [Related]
3. The effect of three human recombinant hematopoietic growth factors (granulocyte-macrophage colony-stimulating factor, granulocyte colony-stimulating factor, and interleukin-3) on phagocyte oxidative activity. Sullivan GW; Carper HT; Mandell GL Blood; 1993 Apr; 81(7):1863-70. PubMed ID: 7681704 [TBL] [Abstract][Full Text] [Related]
4. Immunological effects of amphotericin B and liposomal amphotericin B on splenocytes from immune-normal and immune-compromised mice. Schindler JJ; Warren RP; Allen SD; Jackson MK Antimicrob Agents Chemother; 1993 Dec; 37(12):2716-21. PubMed ID: 8109941 [TBL] [Abstract][Full Text] [Related]
5. Dissociated effect of amphotericin B and desoxycholate on phagocytosis of Escherichia coli by human polymorphonuclear neutrophils. Lingaas E; Midtvedt T Drugs Exp Clin Res; 1985; 11(11):747-54. PubMed ID: 3915464 [TBL] [Abstract][Full Text] [Related]
6. Effects of antifungal agents on the function of human neutrophils in vitro. Roilides E; Walsh TJ; Rubin M; Venzon D; Pizzo PA Antimicrob Agents Chemother; 1990 Feb; 34(2):196-201. PubMed ID: 2158275 [TBL] [Abstract][Full Text] [Related]
7. Miconazole and amphotericin B alter polymorphonuclear leukocyte functions and membrane fluidity in similar fashions. Yasui K; Masuda M; Matsuoka T; Yamazaki M; Komiyama A; Akabane T; Murata K Antimicrob Agents Chemother; 1988 Dec; 32(12):1864-8. PubMed ID: 3245698 [TBL] [Abstract][Full Text] [Related]
9. Synergistic interaction of the triple combination of amphotericin B, ciprofloxacin, and polymorphonuclear neutrophils against Aspergillus fumigatus. Stergiopoulou T; Meletiadis J; Sein T; Papaioannidou P; Walsh TJ; Roilides E Antimicrob Agents Chemother; 2011 Dec; 55(12):5923-9. PubMed ID: 21911564 [TBL] [Abstract][Full Text] [Related]
10. Liposomal amphotericin B and amphotericin B-deoxycholate show different immunoregulatory effects on human peripheral blood mononuclear cells. Reyes E; Cardona J; Prieto A; Bernstein ED; RodrÃguez-Zapata M; Pontes MJ; Alvarez-Mon M J Infect Dis; 2000 Jun; 181(6):2003-10. PubMed ID: 10837182 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of sodium deoxycholate sulfate as a lipid drug carrier to enhance the solubility, stability and safety of an amphotericin B inhalation formulation. Gangadhar KN; Adhikari K; Srichana T Int J Pharm; 2014 Aug; 471(1-2):430-8. PubMed ID: 24907597 [TBL] [Abstract][Full Text] [Related]
12. In-vitro effects of cilofungin (LY121019), amphotericin B and amphotericin B-deoxycholate on human polymorphonuclear leucocytes. Van der Auwera P; Meunier F J Antimicrob Chemother; 1989 Nov; 24(5):747-63. PubMed ID: 2557318 [TBL] [Abstract][Full Text] [Related]
13. Super aggregated form of Amphotericin B: a novel way to increase its therapeutic index. Zia Q; Azhar A; Kamal MA; Aliev G; Owais M; Ashraf GM Curr Pharm Des; 2016; 22(7):792-803. PubMed ID: 26648472 [TBL] [Abstract][Full Text] [Related]
14. Glycogen metabolism in stored granulocytes. Lane TA; Lamkin GE Transfusion; 1985; 25(3):246-50. PubMed ID: 4002309 [TBL] [Abstract][Full Text] [Related]
15. Study of the toxicity of a new lipid complex formulation of amphotericin B. Larabi M; Pages N; Pons F; Appel M; Gulik A; Schlatter J; Bouvet S; Barratt G J Antimicrob Chemother; 2004 Jan; 53(1):81-8. PubMed ID: 14657087 [TBL] [Abstract][Full Text] [Related]
16. Assessment of effective renal plasma flow, enzymuria, and cytokine release in healthy volunteers receiving a single dose of amphotericin B desoxycholate. Pai MP; Norenberg JP; Telepak RA; Sidney DS; Yang S Antimicrob Agents Chemother; 2005 Sep; 49(9):3784-8. PubMed ID: 16127053 [TBL] [Abstract][Full Text] [Related]
17. Chemoattractant receptors of neonatal polymorphonuclear leukocytes: lack of modulation of the receptors by membrane modifier. Yasui K Acta Paediatr Jpn; 1989 Apr; 31(2):150-7. PubMed ID: 2560607 [TBL] [Abstract][Full Text] [Related]
18. Biodistribution and histopathology studies of amphotericin B sodium deoxycholate sulfate formulation following intratracheal instillation in rat models. Usman F; Nopparat J; Javed I; Srichana T Drug Deliv Transl Res; 2020 Feb; 10(1):59-69. PubMed ID: 31368043 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the leishmanicidal activity of fungizone, liposomal AmB and amphotericin B incorporated into egg lecithin-bile salt mixed micelles. Ramos H; Brajtburg J; Marquez V; Cohen BE Drugs Exp Clin Res; 1995; 21(6):211-6. PubMed ID: 8907695 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of a poly-aggregated formulation of amphotericin B in treating systemic sporotrichosis caused by Sporothrix brasiliensis. Ishida K; Castro RA; Torrado JJ; Serrano DR; Borba-Santos LP; Quintella LP; de Souza W; Rozental S; Lopes-Bezerra LM Med Mycol; 2018 Apr; 56(3):288-296. PubMed ID: 28575449 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]